\n\n\n\n\t\t\n\t\t\tVascular Architects\n\t\t\thttp://www.vasculararchitects.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tVascular Architects develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The aSpire Covered Stent and Controlled Expansion Delivery System...More»
\n\t\t\tVascular Architects develops, manufactures and markets devices for treating peripheral vascular disease and nonvascular obstructions. The aSpire Covered Stent and Controlled Expansion Delivery System has been cleared for sale in the U.S. for the treatment of tracheobronchial strictures. The company also markets the MollRing Cutter in the U.S. and Europe for the minimally invasive treatment of iliac and SFA occlusive disease by a procedure known as remote endarterectomy.
Vascular Architects was acquired by LeMaitre Vascular (NASDAQ:LMAT) in September 2007.«Less
Overview
\n\t\t\t\tLocation: \tNashville, TN, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tstents,\n\t\t\t\tdisease,\n\t\t\t\tvascular architects,\n\t\t\t\tlemaitre vascular\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series E - $6.6M (09/04/2004)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tArch Venture Partners,\n\t\t\t\t\t\n\t\tAtherton Venture Partners,\n\t\t\t\t\t\n\t\tDomain Associates,\n\t\t\t\t\t\n\t\tthe Vertical Group,\n\t\t\t\t\t\n\t\tThree Arch Partners,\n\t\t\t\t\t\n\t\tJohnson & Johnson Development Corp,\n\t\t\t\t\t\n\t\tMedtronic\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tSequent Medical,\n\t\t\t\t\t\tStentys\n\t\t\t\t
\n\n\t\t\t